Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of argatroban in heparin-induced thrombocytopenia type II
2008-000730-42Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of argatroban in Heparin-induced thrombocytopenia type 2, sponsored by Mitsubishi Tanabe Pharma Corporation. Primary endpoint: Clinical evaluations. Started Mar 2009; status: completed.
02
Drugs
argatroban
03
Conditions
Heparin-induced thrombocytopenia type 2
Beyond the preview
Go deeper on 2008-000730-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000730-42.